The Director, Global Market Research will help establish BioNTech’s Global commercial market research capabilities for its multiple upcoming global launches in Oncology. You will be part of the best-in-class high-performing team with great visibility to the senior leadership.
Your main taks are:
PRIMARY OBJECTIVES: The Business Development Manager/Senior Manager is a fast-paced, dynamic role, responsible for identifying and developing new opportunities within our Translational Oncology Solutions offering. The BD Manager/Senior Manager will work closely with commercial, marketing, R&D and operations teams to lead business development efforts across the UK/Nordic Region territory. The ideal candidate will have a firm understanding of oncology research and market dynamics.
Isomorphic Labs is applying frontier AI to help unlock deeper scientific insights, faster breakthroughs, and life-changing medicines with an ambition to solve all disease.
The future is coming. A future enabled and enriched by the incredible power of machine learning. A future in which diseases are curtailed or cured starting with better and faster drug discovery.
For 25 years, Isogenica has built deep expertise and knowledge about how to find small-format VHH antibodies (around 1/10th the size of an IgG) and peptides and develop them into drugs in partnership with some of the world’s most innovative biopharma companies.
As an Antibody Discovery Scientist, you will deliver VHH and peptide discovery projects for our partners for use in diverse applications, helping to bring new medicines, diagnostics tools, and other cutting-edge solutions to the world and improve patient lives.
MicroGravity: Just Another Research Environment is an event to help the Life Science sector and explore the value and opportunity from
|
|
The United Kingdom Health Security Agency (UKHSA) is a system leader for health security; taking action internationally to strengthen global health security, providing trusted advice to government and the public and reducing inequalities in the way different communities experience and are impacted by infectious disease, environmental hazards, and other threats to health.
Who we are:
Life, Reimagined
Constructive Bio is a VC-backed biotechnology startup based in Whittlesford, Cambridge. Our unique technology turns living cells into biofactories, creating sustainable new materials and therapeutics. With full control of the genetic sequence and code, we are exploring chemical space previously unreached by natural biology.
Maybe you need an ‘elevator pitch’ for investors. Or just a quick intro for customer meetings or networking. We all have reasons for explaining quickly what our firm is for. This webinar is an interactive workshop designed to help you communicate how you help your customers and what you do better than your competitors.
Stephen Tunnicliffe-Wilson is an exited Founder, Engineer, CTO and CEO. He has spent his career communicating complex subjects in simple terms. Steve has helped many companies improve their pitches to win investment and sell to customers.
This is the first event in a three-part event series which will help growing ventures understand and develop compliance foundations that investors expect.
Early-stage companies such as those in life-sciences operate in one of the most opportunity-rich—and heavily scrutinised—sectors in the UK. As they grow, seek investment, partner with strategic corporates, or prepare for acquisition, investors and financing banks will expect credible, proportionate governance foundations that protect and create value, and minimise avoidable risk.
Tony Jones